메뉴 건너뛰기




Volumn 27, Issue 2, 2011, Pages

Reply to letters from Dr Maria Luz Fernandez, Eddie Vos, and Dr Niva Shapira

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA THROMBOGLOBULIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; OMEGA 3 FATTY ACID; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOXANE B2;

EID: 79960811645     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.12.013     Document Type: Letter
Times cited : (1)

References (5)
  • 1
    • 3142623027 scopus 로고    scopus 로고
    • The cardioprotective effects of statins
    • Davignon J. The cardioprotective effects of statins. Curr Atheroscler Rep 2004;6:27-35.
    • (2004) Curr Atheroscler Rep , vol.6 , pp. 27-35
    • Davignon, J.1
  • 2
    • 33645515465 scopus 로고    scopus 로고
    • High cholesterol intake modifies chylomicron metabolism in normolipidemic young men
    • Cesar TB, Oliveira MR, Mesquita CH, Maranhao RC. High cholesterol intake modifies chylomicron metabolism in normolipidemic young men. J Nutr 2006;136:971-6.
    • (2006) J Nutr , vol.136 , pp. 971-976
    • Cesar, T.B.1    Oliveira, M.R.2    Mesquita, C.H.3    Maranhao, R.C.4
  • 3
    • 64749091722 scopus 로고    scopus 로고
    • Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the Seven Countries Study
    • Menotti A, Lanti M, Kromhout D, et al. Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the Seven Countries Study. Eur J Cardiovasc Prev Rehabil 2008;15:719-25.
    • (2008) Eur J Cardiovasc Prev Rehabil , vol.15 , pp. 719-725
    • Menotti, A.1    Lanti, M.2    Kromhout, D.3
  • 5
    • 58149343413 scopus 로고    scopus 로고
    • Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial
    • Sillesen H, Amarenco P, Hennerici MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008;39:3297-302.
    • (2008) Stroke , vol.39 , pp. 3297-3302
    • Sillesen, H.1    Amarenco, P.2    Hennerici, M.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.